Involvement of caspases and their upstream regulators in myocardial apoptosis in a rat model of selenium deficiency-induced dilated cardiomyopathy

Journal of Trace Elements in Medicine and Biology

Volumn 31, Issue , 2015, Pages 85-91

  Shan, Hu ^a   Yan, Rui ^a   Diao, Jiayu ^a   Lin, Lin ^a   Wang, Suqin ^b   Zhang, Ming ^a   Zhang, Rong ^a   Wei, Jin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Caspase; Keshan disease; Myocardial apoptosis; Selenium deficiency

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CASP3 PROTEIN, RAT; CASP8 PROTEIN, RAT; CASP9 PROTEIN, RAT; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DRUG THERAPY; PEPTIDE FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; SELENIUM;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CHEMISTRY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFICIENCY; DIET SUPPLEMENTATION; DIET THERAPY; DNA FRAGMENTATION; DOWN REGULATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; ENTEROVIRUS INFECTIONS; ENZYME ACTIVITY; ENZYME REGULATION; ENZYMOLOGY; ETIOLOGY; HEART; HEART MUSCLE; IMMUNOREACTIVITY; METABOLISM; NONHUMAN; NUTRITIONAL DEFICIENCY; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SECRETION; RANDOMIZATION; RAT; SELENIUM DEFICIENCY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOOD; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CHEMISTRY; DEFICIENCY; DEFICIENCY DISEASES; DIET THERAPY; DIETARY SUPPLEMENTS; DNA FRAGMENTATION; ECHOCARDIOGRAPHY; ENTEROVIRUS INFECTIONS; ENZYMOLOGY; ETIOLOGY; HEART; METABOLISM; MYOCARDIUM; PATHOLOGY; PEPTIDE FRAGMENTS; PHYSIOPATHOLOGY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; SELENIUM; THERAPEUTIC USE; ULTRASONOGRAPHY;

RATTUS;

EID: 84940163220     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2015.03.005     Document Type: Article

References (33)

1. Rayman M.P. Selenium and human health. Lancet 2012, 379(9822):1256-1268.
2. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356(9225):233-241.
3. Lu J., Holmgren A. Selenoproteins. J Biol Chem 2009, 284(2):723-727.
4. Reeves M.A., Hoffmann P.R. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 2009, 66(15):2457-2478.
5. Brigelius-Flohé R., Maiorino M. Glutathione peroxidases. Biochim Biophys Acta 2013, 1830(5):3289-3303.
6. Cejudo F.J., Ferrández J., Cano B., Puerto-Galán L., Guinea M. The function of the NADPH thioredoxin reductase C-2-Cys peroxiredoxin system in plastid redox regulation and signalling. FEBS Lett 2012, 586(18):2974-2980.
7. Kieliszek M., Błaz˙ejak S. Selenium: significance, and outlook for supplementation. Nutrition 2013, 29(5):713-718.
8. Zeng H., Combs G.F. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 2008, 19(1):1-7.
9. Loscalzo J. Keshan disease: selenium deficiency, and the selenoproteome. N Engl J Med 2014, 370(18):1756-1760.
10. Li Q., Liu M., Hou J., Jiang C., Li S., Wang T. The prevalence of Keshan disease in China. Int J Cardiol 2013, 168(2):1121-1126.
11. Yang J., Wang T., Wu C., Liu C. Selenium level surveillance for the year 2007 of Keshan disease in endemic areas and analysis on surveillance results between 2003 and 2007. Biol Trace Elem Res 2010, 138(1-3):53-59.
12. Xu G.L., Wang S.C., Gu B.Q., et al. Further investigation on the role of selenium deficiency in the aetiology and pathogenesis of Keshan disease. Biomed Environ Sci 1997, 10(2-3):316-326.
13. Xu G.L. The effectiveness of sodium selenite on prevention of acute attacks of Keshan diseases. Chin Med J 1979, 92(7):471-476.
14. Li G., Wang F., Kang D., Li C. Keshan disease: an endemic cardiomyopathy in China. Hum Pathol 1985, 16(6):602-609.
15. Zhong X.K., Yu B., Zhang L.J., Zhou L.W., Qian S.J., Li H., et al. Myocardial injury of Keshan disease and apoptosis. Chin J Endemiol 1997, 16(2):81-82.
16. Wang S.Q., Niu X.L., Liu Z.W., Zhu Y.H., Gao D.F. Selenium deficiency is associated with endoplasmic reticulum stress in a rat model of cardiac malfunction. Biol Trace Elem Res 2013, 156(1-3):196-201.
17. Shan H., Wei J., Wang S., Yan R., Lin L., Zhang M., et al. Selenium deficiency induces apoptosis through endoplasmic reticulum stress in a rat model of endemic dilated cardiomyopathy. Exp Clin Cardiol 2014, 20(8):3076-3081.
18. Pei J., Fu W., Yang L., Zhang Z., Liu Y. Oxidative stress is involved in the pathogenesis of Keshan disease (an endemic dilated cardiomyopathy) in China. Oxid Med Cell Longev 2013, 2013:474203.
19. Kayanoki Y., Fujii J., Islam K.N., Suzuki K., Kawata S., Matsuzawa Y., et al. The protective role of glutathione peroxidase in apoptosis induced by reactive oxygen species. J Biochem 1996, 119(4):817-822.
20. 2 in primary cultured pig thyrocytes. Eur J Endocrinol 2004, 150(6):841-849.
21. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35(4):495-516.
22. Meier P., Finch A., Evan G. Apoptosis in development. Nature 2000, 407(6805):796-801.
23. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305(5684):626-629.
24. Fulda S., Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006, 25(34):4798-4811.
25. Igney F.H., Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002, 2(4):277-288.
26. Yon J.H., Daniel-Johnson J., Carter L.B., Jevtovic-Todorovic V. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005, 135(3):815-827.
27. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis-the p53 network. J Cell Sci 2003, 116(20):4077-4085.
28. Li P.F., Dietz R., von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 1999, 18(21):6027-6036.
29. Schuler M., Bossy-Wetzel E., Goldstein J.C., Fitzgerald P., Green D.R. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 2000, 275(10):7337-7342.
30. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999, 399(6735):483-487.
31. Jürgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci 1998, 95(9):4997-5002.
32. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., et al., et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303(5660):1010-1014.
33. Cregan S.P., MacLaurin J.G., Craig C.G., Robertson G.S., Nicholson D.W., Park D.S., et al. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J Neurosci 1999, 19(18):7860-7869.